Banyan Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.29M Buy
19,879
+847
+4% +$53.6K 0.11% 199
2014
Q2
$1.18M Sell
19,032
-7,192
-27% -$429K 0.1% 219
2014
Q1
$1.54M Sell
26,224
-1,760
-6% -$98.2K 0.13% 179
2013
Q4
$1.43M Buy
27,984
+346
+1% +$17.3K 0.1% 198
2013
Q3
$1.39M Buy
+27,638
New +$1.45M 0.12% 152

Other funds holding LLY

Banyan Partners's LLY Position: Q3 2014 in Review

Banyan Partners increased its Eli Lilly (LLY) stake by 4.5% in Q3 2014, buying an estimated $53.6K and bringing the position to 19,879 shares worth $1.29M. The position accounts for 0.11% of the portfolio, ranked #199.

Banyan Partners first reported a position in LLY in Q3 2013 and has held it in 5 quarters since. The position peaked at $1.54M in Q1 2014. 1,040 funds tracked by Wall St. Rank hold LLY as of Q3 2014.

  • Banyan Partners held 19,879 shares of Eli Lilly worth $1.29M as of Q3 2014.
  • Banyan Partners bought 847 Eli Lilly shares in Q3 2014, an estimated $53.6K.
  • Eli Lilly made up 0.11% of Banyan Partners's portfolio in Q3 2014, its #199 holding.
  • Banyan Partners first reported a position in Eli Lilly in Q3 2013 and has held it in 5 quarters since.
  • Banyan Partners's Eli Lilly position peaked at $1.54M in Q1 2014.
  • 1,040 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.